Insights From Bereaved Parents and Oncologists
Foundations of Communication in Uncertainty Study (FOCUS): Insights From Bereaved Parents and Oncologists
Descripción general del estudio
Estado
Condiciones
Descripción detallada
Primary Objective
- To characterize how bereaved parents of children with cancer and their child's oncologist perceive their experience with communication about prognostic uncertainty during the child's cancer journey and during bereavement.
Secondary Objective
- To elicit parents' and oncologists' preferences and recommendations for how clinicians should talk with children and families about prognosis in the setting of uncertainty.
This study aims to explore bereaved parents' and oncologists' reflections on communication about prognostic uncertainty during the child's cancer treatment. Parents who have lost a child to cancer and the doctors who treated them will be invited to join this study.
Participants who opt to participate in the study will engage in an audio recorded semi-structured interview with a researcher, virtually or in person (at their discretion) to share their perspectives and recommendations based on their experience. Throughout the interview, the interviewer has the option to ask additional questions (i.e., probe with questions not in the interview guide) to respond to comments made by the participant and honor the topics of interest to that given participant. The participant will be provided an opportunity to add any details or comments at the end of the interview if he/she would like to share additional information.
Following completion of the qualitative portion of the interview, the researcher will ask the participant several questions from a demographic form. The demographic form will include questions related to participant age, race/ethnicity, state/country of residence for bereaved parents, and years of clinical practice for oncologists.
Tipo de estudio
Inscripción (Estimado)
Contactos y Ubicaciones
Estudio Contacto
- Nombre: Stephanie Gehle, MD
- Número de teléfono: 888-226-4343
- Correo electrónico: referralinfo@stjude.org
Ubicaciones de estudio
-
-
Tennessee
-
Memphis, Tennessee, Estados Unidos, 38105
- Reclutamiento
- St. Jude Children's Research Hospital
-
Contacto:
- Stephanie Gehle, MD
- Número de teléfono: 888-226-4343
- Correo electrónico: referralinfo@stjude.org
-
Investigador principal:
- Stephanie Gehle, MD
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
- Adulto
- Adulto Mayor
Acepta Voluntarios Saludables
Método de muestreo
Población de estudio
Descripción
Inclusion Criteria:
- All participants must be ≥ 18 years of age or legally emancipated
Parent Participants must have a child who:
- Received cancer care from a clinician at St. Jude, as documented in the electronic medical record, AND
- Died at least 6 months prior to enrollment, but no more than 24 months prior to enrollment.
Oncologist participants at St. Jude must:
- Be listed as the primary oncologist as documented in the electronic medical record, AND
- Have the respective patient's parent agreement to participate in the study.
Exclusion Criteria:
- Declining, refusal, or unwillingness to participate
- Inability or unwillingness of research participant to give informed consent.
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
Cohortes e Intervenciones
Grupo / Cohorte |
|---|
|
Parent Participants
Parents who have lost a child to cancer
|
|
Oncologist Participants
St. Jude doctors who treated the child
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Bereaved parents of children with cancer and oncologists reflections on communication about prognostic uncertainty during the child's cancer treatment
Periodo de tiempo: Approximately 1-3 weeks after enrollment.
|
The analysis plan for this study is to apply reflexive thematic analysis as described by Braun and Clarke, involving the following six step process: 1. Familiarization with the data, 2. Generating initial codes, 3. Generating initial themes, 4. Reviewing themes, 5. Refining, defining, and naming themes, 6. Writing up a narrative of results. Investigators will conduct individual interviews with participants and code transcripts independently to identify salient themes from each cohort, subsequently compare codes across cohorts to explore and characterize areas of convergence and divergence and use a matrix approach to facilitate this comparative analysis. Interviews will be recorded, transcribed, and de-identified prior to analysis. MAXQDA, a sophisticated qualitative analysis software system, will be used to conduct and synthesize analysis. |
Approximately 1-3 weeks after enrollment.
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Stephanie Gehle, MD, St. Jude Children's Research Hospital
Publicaciones y enlaces útiles
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Estimado)
Finalización del estudio (Estimado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- FOCUS
- NCI-2026-05231 (Identificador de registro: NCI Clinical Trial Registration Program)
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .